FUNC vs NBIX
First United Corporation (FUNC) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
First United Corporation (FUNC) is a banks - regional company listed on NASDAQ.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported FUNC revenue for 2024-12-31 was $17.7M. Net income was $20.6M. Revenue was up 6.3% from 2023-12-31 to 2024-12-31. FUNC currently screens at market cap $263.4M and trailing P/E 10.5.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
FUNC currently screens at market cap $263.4M and trailing P/E 10.5. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the FUNC and NBIX stock pages for the full models.
Not investment advice.